Ludwig N. Hantson's most recent trade in Hologic, Inc. was a trade of 5,535 Non-qualified Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hologic | Ludwig N. Hantson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 5,535 | 5,535 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Ludwig N. Hantson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 1,864 | 12,956 (0%) | 0% | - | Common Stock | |
| Hologic | Ludwig N. Hantson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 4,536 | 4,536 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Ludwig N. Hantson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 1,572 | 11,092 (0%) | 0% | - | Common Stock | |
| Hologic | Ludwig N. Hantson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 4,210 | 4,210 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Ludwig N. Hantson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 1,465 | 9,520 (0%) | 0% | - | Common Stock | |
| Hologic | Ludwig N. Hantson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 5,293 | 5,293 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Ludwig N. Hantson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 1,565 | 8,055 (0%) | 0% | - | Common Stock | |
| Hologic | Ludwig N. Hantson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 5,055 | 5,055 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Ludwig N. Hantson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 1,478 | 6,490 (0%) | 0% | - | Common Stock |